Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Remora Biotech

Status
Global HQ
Lausanne, Switzerland
Countries of investment
    Investment stages
      Industries
        About
        Remora Biotech is a cutting-edge biopharmaceutical company dedicated to advancing the field of immunotherapy through the development of innovative treatments for a range of medical conditions, including cancer, autoimmune disorders, and degenerative diseases. Our team comprises highly skilled scientists and patent experts who collaborate to translate groundbreaking research into effective therapeutic solutions. Committed to improving patient outcomes, Remora Biotech leverages state-of-the-art technology and a robust pipeline to deliver next-generation therapies that address unmet medical needs. Through rigorous scientific exploration and a patient-centered approach, we aim to set new standards in the treatment landscape.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Remora Biotech Contacts Information

        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp